Valued at $49.0M at its later-stage round, Apr 2025. Nothing has traded since.
- ·Watch Alessa Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Alessa Therapeutics funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2025 | Early Stage VC | $25.4M | ▮ | ▮ |
| Dec 2019 | Seed Round | $3.3M | ▮ | ▮ |
| Mar 2019 | Seed Round | $3.0M | ▮ | ▮ |
Membership and data by Private Market View
Alessa Therapeutics valuation
Alessa Therapeutics was valued at $49 million at its later-stage round in Apr 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Alessa Therapeutics raised?
Alessa Therapeutics has raised $31.6 million across 3 recorded rounds since 2019. The largest was a $3.3 million seed round in Dec 2019; the most recent was a $25.4 million early-stage round in Apr 2025.
Alessa Therapeutics has filed 3 Form Ds with the SEC since 2019, most recently in May 2025 ($25.4 million sold to 14 investors).
How Alessa Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Alessa Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Alessa Therapeutics
- What is Alessa Therapeutics worth?
- Alessa Therapeutics is valued at $49.0M as of Oct 2026. Valued at $49.0M at its later-stage round, Apr 2025. Nothing has traded since.
- How much has Alessa Therapeutics raised?
- Alessa Therapeutics has raised $31.6M in total funding across 3 recorded rounds.
- When did Alessa Therapeutics last raise?
- Alessa Therapeutics last raised in Apr 2025 (Early Stage VC), raising $25.4M.